Ophthalmology, ISSN 0161-6420, 2013, Volume 120, Issue 1, pp. 130 - 139
To evaluate long-term safety of intravitreal ranibizumab 0.5-mg injections in neovascular age-related macular degeneration (nAMD). Twenty-four-month,...
TRIAL | OPHTHALMOLOGY | VERTEPORFIN PHOTODYNAMIC THERAPY | RANIBIZUMAB | Antibodies, Monoclonal, Humanized - adverse effects | Intraocular Pressure - drug effects | Prospective Studies | Cataract - chemically induced | Double-Blind Method | Follow-Up Studies | Intravitreal Injections | Humans | Male | Wet Macular Degeneration - physiopathology | Angiogenesis Inhibitors - administration & dosage | Visual Acuity - drug effects | Antibodies, Monoclonal, Humanized - administration & dosage | Retinal Hemorrhage - chemically induced | Wet Macular Degeneration - drug therapy | Ranibizumab | Ocular Hypertension - chemically induced | Female | Aged | Angiogenesis Inhibitors - adverse effects | Visual Acuity - physiology
TRIAL | OPHTHALMOLOGY | VERTEPORFIN PHOTODYNAMIC THERAPY | RANIBIZUMAB | Antibodies, Monoclonal, Humanized - adverse effects | Intraocular Pressure - drug effects | Prospective Studies | Cataract - chemically induced | Double-Blind Method | Follow-Up Studies | Intravitreal Injections | Humans | Male | Wet Macular Degeneration - physiopathology | Angiogenesis Inhibitors - administration & dosage | Visual Acuity - drug effects | Antibodies, Monoclonal, Humanized - administration & dosage | Retinal Hemorrhage - chemically induced | Wet Macular Degeneration - drug therapy | Ranibizumab | Ocular Hypertension - chemically induced | Female | Aged | Angiogenesis Inhibitors - adverse effects | Visual Acuity - physiology
Journal Article
Clinical Ophthalmology, ISSN 1177-5467, 05/2014, Volume 8, pp. 945 - 948
We report an unusual case of choroidal neovascularization secondary to intraocular foreign body (IOFB) penetrating trauma. A 44-year-old man was referred to...
Choroidal rupture | Intravitreal | Antivascular endothelial growth factor | Choroidal neovascularization | Intraocular foreign body | Open globe injury | Eye | Case studies | Usage | Care and treatment | Diagnosis | Optical tomography | Injuries | Risk factors | Cataracts | Medical imaging | Medical prognosis | Retina | Ophthalmology | Patients | Vascular endothelial growth factor | Trauma | Hemorrhage | Surgery | Rupture | Regression | Visual acuity | Growth factors | Foreign bodies | Visual | open globe injury | intravitreal | choroidal rupture | choroidal neovascularization | antivascular endothelial growth factor | intraocular foreign body
Choroidal rupture | Intravitreal | Antivascular endothelial growth factor | Choroidal neovascularization | Intraocular foreign body | Open globe injury | Eye | Case studies | Usage | Care and treatment | Diagnosis | Optical tomography | Injuries | Risk factors | Cataracts | Medical imaging | Medical prognosis | Retina | Ophthalmology | Patients | Vascular endothelial growth factor | Trauma | Hemorrhage | Surgery | Rupture | Regression | Visual acuity | Growth factors | Foreign bodies | Visual | open globe injury | intravitreal | choroidal rupture | choroidal neovascularization | antivascular endothelial growth factor | intraocular foreign body
Journal Article
Ophthalmic Research, ISSN 0030-3747, 10/2015, Volume 54, Issue 3, pp. 112 - 117
Purpose: To identify the retinal layer predominantly affected in eyes with subclinical and clinical macular edema in diabetes type 2. Methods: A cohort of 194...
Original Paper | Diabetic retinopathy | Macular edema | Diabetes | Optical coherence tomography | IMAGES | SEGMENTATION | OPHTHALMOLOGY | RETINOPATHY | AGE | Prospective Studies | Tomography, Optical Coherence | Humans | Middle Aged | Organ Size | Male | Young Adult | Diabetes Mellitus, Type 2 - diagnosis | Diabetic Retinopathy - diagnosis | Macular Edema - etiology | Algorithms | Macular Edema - diagnosis | Aged, 80 and over | Adult | Female | Aged | Retinal Neurons - pathology | Diabetic Retinopathy - etiology | Diabetes Mellitus, Type 2 - complications
Original Paper | Diabetic retinopathy | Macular edema | Diabetes | Optical coherence tomography | IMAGES | SEGMENTATION | OPHTHALMOLOGY | RETINOPATHY | AGE | Prospective Studies | Tomography, Optical Coherence | Humans | Middle Aged | Organ Size | Male | Young Adult | Diabetes Mellitus, Type 2 - diagnosis | Diabetic Retinopathy - diagnosis | Macular Edema - etiology | Algorithms | Macular Edema - diagnosis | Aged, 80 and over | Adult | Female | Aged | Retinal Neurons - pathology | Diabetic Retinopathy - etiology | Diabetes Mellitus, Type 2 - complications
Journal Article
Retina, ISSN 0275-004X, 04/2009, Volume 29, Issue 4, pp. 530 - 535
To determine whether an intravitreal bevacizumab injection after phacoemulsification can improve cataract surgery visual outcomes in patients with diabetic...
Cataract | Phacoemulsification | Diabetic macular edema | Bevacizumab | Diabetic Retinopathy - drug therapy | Humans | Postoperative Period | Vascular Endothelial Growth Factor A - antagonists & inhibitors | Visual Acuity | Disease Progression | Preoperative Care | Diabetic Retinopathy - physiopathology | Antibodies, Monoclonal, Humanized | Injections | Pilot Projects | Postoperative Care | Vision Disorders - prevention & control | Antibodies, Monoclonal - administration & dosage | Macular Edema - physiopathology | Cataract Extraction - adverse effects | Macular Edema - drug therapy | Vitreous Body | Vision Disorders - etiology
Cataract | Phacoemulsification | Diabetic macular edema | Bevacizumab | Diabetic Retinopathy - drug therapy | Humans | Postoperative Period | Vascular Endothelial Growth Factor A - antagonists & inhibitors | Visual Acuity | Disease Progression | Preoperative Care | Diabetic Retinopathy - physiopathology | Antibodies, Monoclonal, Humanized | Injections | Pilot Projects | Postoperative Care | Vision Disorders - prevention & control | Antibodies, Monoclonal - administration & dosage | Macular Edema - physiopathology | Cataract Extraction - adverse effects | Macular Edema - drug therapy | Vitreous Body | Vision Disorders - etiology
Journal Article
Ophthalmic Research, ISSN 0030-3747, 10/2015, Volume 54, Issue 3, pp. 118 - 123
Purpose: To characterize the 1-year progression of retinal thickness (RT) increase occurring in eyes with subclinical macular edema in type 2 diabetes....
Original Paper | Diabetic retinopathy | Macular edema | Diabetes | Optical coherence tomography | OPHTHALMOLOGY | MICROANEURYSM TURNOVER | Prospective Studies | Tomography, Optical Coherence | Humans | Middle Aged | Organ Size | Male | Disease Progression | Diabetic Retinopathy - diagnosis | Algorithms | Macular Edema - diagnosis | Aged, 80 and over | Adult | Female | Aged | Retinal Neurons - pathology | Diabetes Mellitus, Type 2 - complications
Original Paper | Diabetic retinopathy | Macular edema | Diabetes | Optical coherence tomography | OPHTHALMOLOGY | MICROANEURYSM TURNOVER | Prospective Studies | Tomography, Optical Coherence | Humans | Middle Aged | Organ Size | Male | Disease Progression | Diabetic Retinopathy - diagnosis | Algorithms | Macular Edema - diagnosis | Aged, 80 and over | Adult | Female | Aged | Retinal Neurons - pathology | Diabetes Mellitus, Type 2 - complications
Journal Article
Investigative ophthalmology & visual science, ISSN 0146-0404, 2015, Volume 56, Issue 9, pp. 5698 - 5705
PURPOSE. To identify eyes of patients with diabetes type 2 that show progression of retinal disease within a 1-year period using noninvasive techniques....
Biomarkers | Diabetic retinopathy | Microaneurysms | Macular edema | Diabetes type 2 | MICROANEURYSM TURNOVER | biomarkers | OPHTHALMOLOGY | SIGNIFICANT MACULAR EDEMA | macular edema | diabetes type 2 | microaneurysms | diabetic retinopathy | THICKNESS | Prognosis | Prospective Studies | Follow-Up Studies | Humans | Middle Aged | Male | Tomography, Optical Coherence - methods | Visual Acuity | Disease Progression | Diabetic Retinopathy - physiopathology | Diabetic Retinopathy - diagnosis | Time Factors | Female | Diabetic Retinopathy - etiology | Retina - pathology | Diabetes Mellitus, Type 2 - complications
Biomarkers | Diabetic retinopathy | Microaneurysms | Macular edema | Diabetes type 2 | MICROANEURYSM TURNOVER | biomarkers | OPHTHALMOLOGY | SIGNIFICANT MACULAR EDEMA | macular edema | diabetes type 2 | microaneurysms | diabetic retinopathy | THICKNESS | Prognosis | Prospective Studies | Follow-Up Studies | Humans | Middle Aged | Male | Tomography, Optical Coherence - methods | Visual Acuity | Disease Progression | Diabetic Retinopathy - physiopathology | Diabetic Retinopathy - diagnosis | Time Factors | Female | Diabetic Retinopathy - etiology | Retina - pathology | Diabetes Mellitus, Type 2 - complications
Journal Article
Ophthalmic Research, ISSN 0030-3747, 12/2015, Volume 55, Issue 1, pp. 19 - 25
Purpose: To characterize the relevance of macular thickness changes in the inner and outer rings in the progression of macular edema in eyes/patients with...
Original Paper | Diabetic retinopathy | Macular edema | Diabetes | Optical coherence tomography | Prospective Studies | Follow-Up Studies | Tomography, Optical Coherence | Humans | Middle Aged | Diabetic Retinopathy - classification | Organ Size | Male | Disease Progression | Macular Edema - classification | Diabetic Retinopathy - diagnosis | Sensitivity and Specificity | Macular Edema - diagnosis | Aged, 80 and over | Adult | Female | Aged | Retina - pathology | Visual Acuity - physiology | Diabetes Mellitus, Type 2 - complications
Original Paper | Diabetic retinopathy | Macular edema | Diabetes | Optical coherence tomography | Prospective Studies | Follow-Up Studies | Tomography, Optical Coherence | Humans | Middle Aged | Diabetic Retinopathy - classification | Organ Size | Male | Disease Progression | Macular Edema - classification | Diabetic Retinopathy - diagnosis | Sensitivity and Specificity | Macular Edema - diagnosis | Aged, 80 and over | Adult | Female | Aged | Retina - pathology | Visual Acuity - physiology | Diabetes Mellitus, Type 2 - complications
Journal Article
Retinal cases & brief reports, ISSN 1935-1089, 2008, Volume 2, Issue 3, pp. 250 - 252
To report the features of a case with late-onset fundus flavimaculatus (FFM) complicated by choroidal neovascularization (CNV) and treated with ranibizumab....
Journal Article
Journal of Ophthalmology, ISSN 2090-004X, 2014, Volume 2014, pp. 210458 - 8
We treated 26 eyes of 25 young patients having a mean age of 30 years with intravitreal vascular endothelial growth factor (VEGF) inhibitor for choroidal new...
MEDICINE, RESEARCH & EXPERIMENTAL | PHOTODYNAMIC THERAPY | BEVACIZUMAB | MEMBRANE | SECONDARY | OPHTHALMOLOGY | PATIENT | RANIBIZUMAB | Clinical Study
MEDICINE, RESEARCH & EXPERIMENTAL | PHOTODYNAMIC THERAPY | BEVACIZUMAB | MEMBRANE | SECONDARY | OPHTHALMOLOGY | PATIENT | RANIBIZUMAB | Clinical Study
Journal Article
Case reports in transplantation, ISSN 2090-6943, 2012, Volume 2012, pp. 305920 - 5
Infections are one of the leading causes of morbidity and mortality in heart transplantation (HTx). Cytomegalovirus (CMV) is the most common viral infection...
Case Report
Case Report
Journal Article
13.
Full Text
Photodynamic therapy directly over the optic nerve head to treat a papillary hemangioma
Retinal cases & brief reports, ISSN 1935-1089, 2008, Volume 2, Issue 4, pp. 328 - 331
To show how effective photodynamic therapy (PDT) is for papillary hemangioma. During follow-up, a papillary hemangioma in a 7-year-old girl increased in size,...
Journal Article
Ophthalmology, ISSN 0161-6420, 12/1995, Volume 102, Issue 12, pp. 1736 - 1737
Journal Article
15.
Full Text
Inefficacy of Low-Dose Intraoperative Fluorouracil in the Treatment of Primary Pterygium
Archives of Ophthalmology, ISSN 0003-9950, 11/1995, Volume 113, Issue 11, pp. 1356 - 1357
We have recently reported a 3.3% recurrence rate for pterygium after the intraoperative use of 0.1-mg/mL mitomycin as an adjunctive therapy to surgery.1...
OPHTHALMOLOGY | Recurrence | Prospective Studies | Double-Blind Method | Follow-Up Studies | Humans | Middle Aged | Male | Antimetabolites, Antineoplastic - administration & dosage | Pterygium - drug therapy | Fluorouracil - therapeutic use | Antimetabolites, Antineoplastic - therapeutic use | Fluorouracil - administration & dosage | Pterygium - surgery | Intraoperative Care | Pterygium - etiology | Female | Chemotherapy, Adjuvant
OPHTHALMOLOGY | Recurrence | Prospective Studies | Double-Blind Method | Follow-Up Studies | Humans | Middle Aged | Male | Antimetabolites, Antineoplastic - administration & dosage | Pterygium - drug therapy | Fluorouracil - therapeutic use | Antimetabolites, Antineoplastic - therapeutic use | Fluorouracil - administration & dosage | Pterygium - surgery | Intraoperative Care | Pterygium - etiology | Female | Chemotherapy, Adjuvant
Journal Article
Ophthalmic Research, ISSN 0030-3747, 06/2010, Volume 44, Issue 1, pp. 57 - 80
Journal Article
No results were found for your search.
Cannot display more than 1000 results, please narrow the terms of your search.